Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Authors: Olivry, Thierry; Mayhew, David; Paps, Judy S.; Linder, Keith E.; Peredo, Carlos; Rajpal, Deepak; Hofland, Hans; Cote-Sierra, Javier
Abstract
Determining inflammation and itch pathway activation in patients with atopic dermatitis (AD) is fraught with the inability to precisely assess the age of skin lesions, thus affecting the analysis of time-dependent mediators. To characterize inflammatory events occurring during early experimental acute AD lesions, biopsy samples were collected 6, 24, and 48 hours after epicutaneous application of Dermatophagoides farinae house dust mites to sensitized atopic dogs. The skin transcriptome was assessed using a dog-specific microarray and quantitative PCR. Acute canine AD skin lesions had a significant up-regulation of genes encoding T helper (Th) 2 (e.g., IL4, IL5, IL13, IL31, and IL33), Th9 (IL9), and Th22 (IL22) cytokines as well as Th2-promoting chemokines such as CCL5 and CCL17. Proinflammatory (e.g., IL6, LTB, and IL18) cytokines were also up-regulated. Other known pruritogenic pathways were also activated: there was significant up-regulation of genes encoding proteases cathepsin S (CTSS), mast cell chymase (CMA1), tryptase (TPS1) and mastin, neuromedin-B (NMB), nerve growth factor (NGF), and leukotriene-synthesis enzymes (ALOX5, ALOX5AP, and LTA4H). Experimental acute canine house dust mite-induced AD lesions exhibit an activation of innate and adaptive immune responses and pruritogenic pathways similar to those seen in humans with acute AD, thereby validating this model to test innovative therapeutics modalities for this disease.
Immunochip analysis identifies association of the RAD50/IL13 region with human longevity
AGING CELL
Authors: Flachsbart, Friederike; Ellinghaus, David; Gentschew, Liljana; Heinsen, Femke-Anouska; Caliebe, Amke; Christiansen, Lene; Nygaard, Marianne; Christensen, Kaare; Blanche, Helene; Deleuze, Jean-Francois; Derbois, Celine; Galan, Pilar; Buening, Carsten; Brand, Stephan; Peters, Anette; Strauch, Konstantin; Mueller-Nurasyid, Martina; Hoffmann, Per; Noethen, Markus M.; Lieb, Wolfgang; Franke, Andre; Schreiber, Stefan; Nebel, Almut
Abstract
Human longevity is characterized by a remarkable lack of confirmed genetic associations. Here, we report on the identification of a novel locus for longevity in the RAD50/IL13 region on chromosome 5q31.1 using a combined European sample of 3208 long-lived individuals (LLI) and 8919 younger controls. First, we performed a large-scale association study on 1458 German LLI (mean age 99.0years) and 6368 controls (mean age 57.2years) by targeting known immune-associated loci covered by the Immunochip. The analysis of 142136 autosomal single nucleotide polymorphisms (SNPs) revealed an Immunochip-wide significant signal (P-Immunochip=7.01x10(-9)) for the SNP rs2075650 in the TOMM40/APOE region, which has been previously described in the context of human longevity. To identify novel susceptibility loci, we selected 15 markers with P-Immunochip<5x10(-4) for replication in two samples from France (1257 LLI, mean age 102.4years; 1811 controls, mean age 49.1years) and Denmark (493 LLI, mean age 96.2years; 740 controls, mean age 63.1years). The association at SNP rs2706372 replicated in the French study collection and showed a similar trend in the Danish participants and was also significant in a meta-analysis of the combined French and Danish data after adjusting for multiple testing. In a meta-analysis of all three samples, rs2706372 reached a P-value of PImmunochip+Repl=5.42x10(-7) (OR=1.20; 95% CI=1.12-1.28). SNP rs2706372 is located in the extended RAD50/IL13 region. RAD50 seems a plausible longevity candidate due to its involvement in DNA repair and inflammation. Further studies are needed to identify the functional variant(s) that predispose(s) to a long and healthy life.